コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 lymphocytic choriomeningitis virus and human parainfluenza virus type 3.
2 ion, which was 40-fold lower than that of WT parainfluenza virus type 3.
4 s of a live-attenuated vaccine candidate for parainfluenza virus type 3, an enveloped RNA virus that
6 tial innate antiviral response against human parainfluenza virus type 3 and respiratory syncytial vir
7 yncytial virus, human metapneumovirus, human parainfluenza virus type 3, and measles virus, and highl
8 fever (SF) and Kansas (Ka) strains of bovine parainfluenza virus type 3 (BPIV3) are restricted in the
11 raminidase (HN) glycoprotein genes of bovine parainfluenza virus type 3 (BPIV3) to its restricted rep
12 to evaluate the antibody responses to bovine parainfluenza virus type 3 (bPIV3) vaccination in young
15 uses, including the childhood pathogen human parainfluenza virus type 3, enter host cells by fusion o
16 explores the binding and entry into cells of parainfluenza virus type 3, focusing on how the receptor
21 erence have not been characterized for human parainfluenza virus type 3 (HPF3), and the possible role
23 ur previous observation on the role of human parainfluenza virus type 3 (HPIV 3) C protein in the tra
25 paramyxovirus simian virus 5 (SV5) and human parainfluenza virus type 3 (HPIV-3) fusion (F) proteins
30 es, respiratory syncytial virus (RSV), human parainfluenza virus type 3 (HPIV-3), and measles virus (
31 on factor, with the cis-acting RNAs of human parainfluenza virus type 3 (HPIV3) and packaging of thes
32 valent live attenuated vaccine against human parainfluenza virus type 3 (HPIV3) and respiratory syncy
33 respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (HPIV3) are major pediatric r
34 respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (HPIV3) are major viral agent
35 SV), human metapneumovirus (hMPV), and human parainfluenza virus type 3 (hPIV3) are responsible for t
36 Respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (HPIV3) are the first and sec
37 Respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (HPIV3) are two major causes
41 genes, of a gene cassette encoding the human parainfluenza virus type 3 (HPIV3) hemagglutinin-neurami
42 t also the receptor interaction of the human parainfluenza virus type 3 (HPIV3) hemagglutinin-neurami
43 plementation to follow the dynamics of human parainfluenza virus type 3 (HPIV3) HN/F pairs in living
49 onnected to the stalk region of either human parainfluenza virus type 3 (HPIV3) or Nipah virus recept
51 binant virus rHPIV3-N(B), a version of human parainfluenza virus type 3 (HPIV3) that is attenuated du
52 against Ebola virus (EV), recombinant human parainfluenza virus type 3 (HPIV3) was modified to expre
53 rt here that for three paramyxoviruses-human parainfluenza virus type 3 (HPIV3), a major cause of low
55 monkeys 100- to 1,000-fold compared to human parainfluenza virus type 3 (HPIV3), and the Ka strain al
56 common pediatric respiratory pathogen, human parainfluenza virus type 3 (HPIV3), as a vaccine vector
57 encephalomyocarditis virus (EMCV) and human parainfluenza virus type 3 (HPIV3), induced down-regulat
58 ing the childhood respiratory pathogen human parainfluenza virus type 3 (HPIV3), possess an envelope
64 s virus of the Arenaviridae family and human parainfluenza virus type 3 of the Paramyxoviridae family
65 paramyxoviruses, Sendai virus (SN) and human parainfluenza virus type 3 (PI3), was constructed and co
67 respiratory syncytial virus (RSV) and human parainfluenza virus type-3 (PIV-3) mediate virus entry a
68 nd attenuation (att) phenotypes of the human parainfluenza virus type 3 (PIV3) cp45 live attenuated v
69 In this study, a chimeric bovine/human (b/h) parainfluenza virus type 3 (PIV3) expressing the human P
77 r the ability to inhibit the growth of human parainfluenza virus type 3 (PIV3), a nonsegmented negati
84 minidase abolished infection of HAE by human parainfluenza virus type 3, this treatment did not signi
85 vaccine for respiratory syncytial virus and parainfluenza virus type 3, two major causes of severe r
86 protective efficacy of an aerosolized human parainfluenza virus type 3-vectored vaccine that express
87 viruses, including the human pathogen human parainfluenza virus type 3, yet these compounds by thems
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。